Arkolith/Insider Trading/IGC/Form 4

Mukunda Ram

CEO, DirectorIGC Pharma, Inc. (IGC) · full profile →Form 4 · filed Apr 6, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
4 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2026Option exercise(M)333K—$04.3M
Apr 1, 2026Option exercise(M)323K$0.26$84K4.6M
Apr 1, 2026Option exercise(M)17K—$0877K
Apr 1, 2026Option exercise(M)33K—$0911K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2026Option exercise(M)333K—$00
Apr 1, 2026Option exercise(M)323K—$0677K
Apr 1, 2026Option exercise(M)17K—$00
Apr 1, 2026Option exercise(M)33K—$033K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001185185-26-001285) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML